Hostname: page-component-68c7f8b79f-gx2m9 Total loading time: 0 Render date: 2025-12-23T03:18:21.405Z Has data issue: false hasContentIssue false

High-functioning depression: a hidden burden demanding clinical recognition

Published online by Cambridge University Press:  23 December 2025

Promise U. Okereke*
Affiliation:
Faculty of Dentistry, College of Medicine, University of Nigeria, Enugu, Nigeria Global Leadership Dentistry and Sciences, Washington, District of Columbia, USA Alliance for Oral Health Across Borders, New York, New York, USA
Chukwuemeka V. Umeh
Affiliation:
Faculty of Clinical Sciences, College of Medicine, University of Nigeria, Enugu, Nigeria Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Wisdom O. Okereke
Affiliation:
Faculty of Dentistry, College of Medicine, University of Nigeria, Enugu, Nigeria Ideal Dental Foundation International, Abuja, Nigeria
Egide Ndayambaje
Affiliation:
College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda Research Department, OLGNova, Kigali, Rwanda
Christian C. Obetta
Affiliation:
Faculty of Clinical Sciences, College of Medicine, University of Nigeria, Enugu, Nigeria Department of Public Health, Oxford Brookes University, Oxford, UK
Onyedikachi F. Uzor
Affiliation:
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Olanrewaju J. Oduola
Affiliation:
Department of Periodontology and Community Dentistry, University College Hospital, Ibadan, Nigeria
*
Correspondence to Promise U. Okereke (promise.okereke.240740@unn.edu.ng)
Rights & Permissions [Opens in a new window]

Summary

High-functioning depression (HFD) describes individuals experiencing persistent depressive symptoms, such as low mood and emotional exhaustion, while maintaining outward success. Owing to preserved functionality, the underlying distress is often unnoticed, misattributed or suppressed. HFD challenges existing psychiatric frameworks, delays diagnosis and increases the risk of progression to major depressive disorder and suicidality. Current screening tools may lack sensitivity, and stigma can lead to disengagement from therapy. Expanded diagnostic awareness, improved clinician training and culturally attuned care are essential for recognising and validating internal suffering in this overlooked population.

Information

Type
Editorial
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

High-functioning depression (HFD) is an increasingly recognised presentation in psychiatric practice, although it remains diagnostically undefined. Reference Joseph, Tural, Joseph, Mendoza, Patel and Reifer1 The term ‘high-functioning depression’ has appeared intermittently in clinical discourse and popular psychology since the late 20th century, often as an informal descriptor for individuals who meet criteria for persistent depressive disorder while maintaining social and occupational roles. Reference Jones2 Although not formally recognised in DSM-5 or ICD-11, just like some other atypical depressive conditions, HFD is becoming increasingly acknowledged in clinical commentary and practice discussions. Reference Joseph, Tural, Joseph, Mendoza, Patel and Reifer1,Reference Jones2 Individuals affected often experience enduring symptoms of depression while continuing to perform professionally and socially, thus maintaining outward success and social functionality. Reference Jones2 These individuals may appear well-adjusted, productive and emotionally stable, yet silently endure persistent low mood, fatigue, irritability and emotional detachment. Reference Joseph, Tural, Joseph, Mendoza, Patel and Reifer1,Reference Jones2 Despite substantial internal distress, their ability to meet certain obligations, such as professional, academic or familial obligations, often obscures the severity of their symptoms and therefore their internal psychological burden is often unnoticed, unacknowledged, suppressed or dismissed. Reference Gonda, Pompili, Serafini, Carvalho, Rihmer and Dome3 As a result, HFD remains a blind spot in psychiatric diagnostics, underpinned by a culture that frequently equates visible functionality with mental wellness.

Although HDF is not formally recognised in DSM-5 and ICD-11, it closely overlaps with persistent depressive disorder (dysthymia), albeit with fewer observable functional impairments. In clinical contexts, it challenges the assumption that depression necessarily manifests as noticeable dysfunction. Reference Gonda, Pompili, Serafini, Carvalho, Rihmer and Dome3,Reference Chow, Bowie, Morton, Lalovic, McInerney and Rizvi4 For mental health services globally, this creates a diagnostic lacuna with implications for care, public health and policy.

A challenge to diagnostic assumptions

Current psychiatric frameworks tend to associate depression with functional impairment. Reference Gonda, Pompili, Serafini, Carvalho, Rihmer and Dome3,Reference Chow, Bowie, Morton, Lalovic, McInerney and Rizvi4 In contrast, individuals with HFD often retain high performance in professional or caregiving roles while concealing symptoms. Many may describe themselves as ‘just tired’ or ‘coping under pressure’. In such contexts, clinicians may misattribute signs of distress to occupational stress, personality traits such as perfectionism, or situational burnout. Reference Kim, Zeppenfeld and Cohen5,Reference Baumeister, Dale and Sommer6

Furthermore, conventional screening tools such as the Patient Health Questionnaire-9 or General Anxiety Disorder-7 may inadequately capture subthreshold but persistent symptoms in individuals who minimise their distress. Reference Villarreal-Zegarra, Barrera-Begazo, Otazú-Alfaro, Mayo-Puchoc, Bazo-Alvarez and Huarcaya-Victoria7 This diagnostic ambiguity may delay intervention until the individual reaches a point of collapse, often presenting in crisis or through somatic complaints.

The challenge is compounded in high-functioning populations such as students, physicians, carers and executives, who are socially and professionally incentivised to appear emotionally self-sufficient. Reference Jones2

The paradox of success and silence

The sociocultural perception of depression is often tied to dysfunction. Reference Hirschfeld, Montgomery, Keller, Kasper, Schatzberg and Hans-Jurgen8 However, high-functioning individuals may embody the very traits society rewards: resilience, ambition and self-control. For many, these traits mask vulnerability. Reference Kim, Zeppenfeld and Cohen5,Reference Baumeister, Dale and Sommer6

Women, ethnic minorities and professionals in high-pressure environments may feel an implicit obligation to maintain a composed façade. Reference Kim, Zeppenfeld and Cohen5,Reference Baumeister, Dale and Sommer6,Reference Lee9 Studies have found that such individuals often internalise the belief that they are ‘not unwell enough’ to seek help, particularly if their suffering is not externally visible. Reference Hirschfeld, Montgomery, Keller, Kasper, Schatzberg and Hans-Jurgen8,Reference Lee9

This paradox is exacerbated by mass media representations that either dramatise breakdowns or celebrate ‘toughness’ in adversity. The deaths of public figures who appeared successful on the surface highlight the limits of our current diagnostic paradigms. Reference Lee9 Yet, clinical reforms rarely follow these public reckonings. Also, the interplay of chronic stress should not be underestimated, as these stressors, be they environmental, neuroendocrinological and/or genetic, further compound the silent progression to a major depressive condition. Reference Tafet and Nemeroff10,Reference Tafet and Bernardini11 It is noteworthy that HFD may be preceded and/or triggered by burnout, as their symptoms, masking and treatments most likely overlap. Reference Koutsimani, Montgomery and Georganta12

Clinical and public health implications

Delayed recognition of HFD carries significant risks. Prolonged low-grade depression can evolve into major depressive episodes, increase suicidality and result in comorbid anxiety or substance use disorders. Reference Sekowski and Prigerson13 Beyond mental illness, persistent depressive symptoms are linked to cardiovascular morbidity, sleep disturbance and diminished immune function. Reference Adroa Afiya14

Clinically, people with HFD may be reluctant to engage in treatment. Reference Baumeister, Dale and Sommer6 This is not due to pharmacological resistance, but behavioural ambivalence. Patients may question the legitimacy of their need for help, feel guilt for seeking care or withdraw from therapy once external performance improves. Reference Kim, Zeppenfeld and Cohen5,Reference Baumeister, Dale and Sommer6 Psychotherapeutic approaches such as cognitive–behavioural therapy and compassion-focused therapy may need to be adapted to engage these individuals’ high levels of autonomy, self-criticism and over-control. Reference Gautam, Tripathi, Deshmukh and Gaur15

At a systems level, HFD contributes an invisible burden in primary care workplace environments. Mental health promotion strategies in occupational and educational settings often miss those who are technically ‘functioning’ but quietly deteriorating. Reference Kim, Zeppenfeld and Cohen5

What psychiatry must address

To better serve individuals with HFD, psychiatry must evolve on four fronts.

  1. (a) Broadening of screening practices: screening tools should be adapted to include emotional numbing, perfectionistic coping and internalised distress in high-performing populations.

  2. (b) Recognising subthreshold depression: diagnostic frameworks such as the DSM and ICD should better acknowledge persistent, functionally masked depression and associated distress, as should practice guidelines such as those published by National Institute for Health and Care Excellence (NICE), American Psychiatric Association and World Health Organization.

  3. (c) Ensuring cultural and identity awareness: training should equip clinicians to recognise how gender, culture and socio-professional identity influence help-seeking behaviours and symptom expression.

  4. (d) Developing future research: further research is urgently needed to better understand this form of depression, particularly its prevalence, specific symptoms, screening/diagnostic tools and management modalities, through longitudinal studies on depression trajectories, qualitative exploration of patients’ personal experiences, and targeted interventions within high-functioning occupational groups.

Conclusion

High-functioning depression underscores the limitations of psychiatric frameworks that equate mental illness primarily with visible dysfunction. By concealing their suffering behind competence, individuals with HFD remain largely invisible to clinicians, employers and even family members, despite enduring persistent distress. This invisibility not only delays recognition and treatment, but also reinforces the cultural myth that outward success is incompatible with mental illness.

Recognition of HFD demands a multidimensional response. Psychiatrists must be attentive to presentations where patients meet external expectations yet express chronic internal struggles. Therefore, classification systems and clinical guidelines such as DSM, ICD and NICE must evolve to account for subthreshold and masked forms of depression. At the same time, broader cultural change is needed to challenge the stigma that equates vulnerability with weakness and well-being with productivity.

Ultimately, addressing HFD requires collaboration across psychiatry, primary care, workplaces and communities. By recognising internal suffering, even when hidden behind achievement, we can close a critical gap in mental healthcare, prevent progression to more severe illness and foster a more compassionate approach to human well-being.

About the authors

Promise U. Okereke, BDS, is a graduate of the Faculty of Dentistry, College of Medicine, University of Nigeria, Enugu, Nigeria; the Nigerian Ambassador of the Global Leadership Dentistry and Sciences, Washington, District of Columbia, USA; a student mentor with the Alliance for Oral Health Across Borders, New York, New York, USA; the Research Director, Youth Health Action Network (YOHAN) Africa, YOHAN Research Institute, Enugu, Nigeria; and the Research Lead, Ideal Dental Foundation International, Abuja, Nigeria. Chukwuemeka V. Umeh, MBBS, is a graduate of the Faculty of Clinical Sciences, College of Medicine, University of Nigeria, Enugu, Nigeria; and a resident doctor at the Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Wisdom O. Okereke, BDS, is graduate of the Faculty of Dentistry, College of Medicine, University of Nigeria, Enugu, Nigeria; the Programs and Community Engagement Officer at Ideal Dental Foundation International, Abuja, Nigeria; and President of the American Academy of Developmental Medicine and Dentistry’s Student Representative Council, Nigeria Chapter. Egide Ndayambaje, MBBS, is a medical student in the College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda; and a researcher at the Research Department, OLGNova, Kigali, Rwanda. Christian C. Obetta, MBBS, is graduate of the Faculty of Clinical Sciences, College of Medicine, University of Nigeria, Enugu, Nigeria; and is pursuing a Master’s degree in public health in the Department of Public Health, Oxford Brookes University, Oxford, UK. Onyedikachi F. Uzor, MBBS, is a resident doctor with Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Olanrewaju J. Oduola, BDS, is a senior registrar in the Department of Periodontology and Community Dentistry, University College Hospital (UCH), Ibadan, Nigeria.

Data availability

Data availability is not applicable to this article as no new data were created or analysed in this study.

Author contributions

P.U.O. and E.N. conceptualised the study. C.V.U., W.O.K., C.C.O., O.F.U. and O.J.O. contributed to the writing of the original and final version.

Funding

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

Declaration of interest

None.

References

Joseph, JF, Tural, U, Joseph, ND, Mendoza, TE, Patel, E, Reifer, R, et al. Understanding high-functioning depression in adults. Cureus 2025; 17: e78891.Google ScholarPubMed
Jones, JT. High functioning: successful professionals with severe mental illness. Duke Forum Law Soc Change 2015; 7: 135.Google Scholar
Gonda, X, Pompili, M, Serafini, G, Carvalho, AF, Rihmer, Z, Dome, P. The role of cognitive dysfunction in the symptoms and remission from depression. Ann Gen Psychiatry 2015; 14: 27.10.1186/s12991-015-0068-9CrossRefGoogle ScholarPubMed
Chow, TK, Bowie, CR, Morton, M, Lalovic, A, McInerney, SJ, Rizvi, SJ. Contributors of functional impairment in major depressive disorder: a biopsychosocial approach. Curr Behav Neurosci Rep 2022; 9: 5972.10.1007/s40473-022-00247-yCrossRefGoogle Scholar
Kim, E, Zeppenfeld, V, Cohen, D. Sublimation, culture, and creativity. J Person Soc Psychol 2013; 105: 639–66.10.1037/a0033487CrossRefGoogle ScholarPubMed
Baumeister, RF, Dale, K, Sommer, KL. Freudian defense mechanisms and empirical findings in modern social psychology: reaction formation, projection, displacement, undoing, isolation, sublimation, and denial. J Person 1998; 66: 1081–124.CrossRefGoogle Scholar
Villarreal-Zegarra, D, Barrera-Begazo, J, Otazú-Alfaro, S, Mayo-Puchoc, N, Bazo-Alvarez, JC, Huarcaya-Victoria, J. Sensitivity and specificity of the Patient Health Questionnaire (PHQ-9, PHQ-8, PHQ-2) and General Anxiety Disorder scale (GAD-7, GAD-2) for depression and anxiety diagnosis: a cross-sectional study in a Peruvian hospital population. BMJ Open 2023; 13: e076193.10.1136/bmjopen-2023-076193CrossRefGoogle Scholar
Hirschfeld, RM, Montgomery, SA, Keller, MB, Kasper, S, Schatzberg, AF, Hans-Jurgen, M, et al. Social functioning in depression: a review. J Clin Psychiatry 2000; 61: 268–75.10.4088/JCP.v61n0405CrossRefGoogle ScholarPubMed
Lee, SY. Media coverage of celebrity suicide caused by depression and increase in the number of people who seek depression treatment. Psychiatry Res 2019; 271: 598603.10.1016/j.psychres.2018.12.055CrossRefGoogle ScholarPubMed
Tafet, GE, Nemeroff, CB. The links between stress and depression: psychoneuroendocrinological, genetic, and environmental interactions. J Neuropsychiatr Clin Neurosci 2016; 28: 7788.10.1176/appi.neuropsych.15030053CrossRefGoogle ScholarPubMed
Tafet, GE, Bernardini, R. Psychoneuroendocrinological links between chronic stress and depression. Progr Neuro-Psychopharmacol Biol Psychiatry 2003; 27: 893903.10.1016/S0278-5846(03)00162-3CrossRefGoogle ScholarPubMed
Koutsimani, P, Montgomery, A, Georganta, K. The relationship between burnout, depression, and anxiety: a systematic review and meta-analysis. Front Psychol 2019; 10: 429219.10.3389/fpsyg.2019.00284CrossRefGoogle ScholarPubMed
Sekowski, M, Prigerson, HG. Associations between symptoms of prolonged grief disorder and depression and suicidal ideation. Br J Clin Psychol 2022; 61: 1211–8.10.1111/bjc.12381CrossRefGoogle ScholarPubMed
Adroa Afiya, B. Interconnection between depressive disorders and persistent diseases. Res Invention J Res Med Sci 2024; 3: 4551.Google Scholar
Gautam, M, Tripathi, A, Deshmukh, D, Gaur, M. Cognitive behavioral therapy for depression. Indian J Psychiatry 2020; 62(suppl 2): S2239.10.4103/psychiatry.IndianJPsychiatry_772_19CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.